Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

SELL
$0.35 - $0.72 $3,385 - $6,964
-9,673 Reduced 26.84%
26,360 $10,000
Q4 2022

Feb 10, 2023

BUY
$0.32 - $8.27 $4,914 - $127,018
15,359 Added 74.29%
36,033 $14,000
Q3 2022

Nov 10, 2022

BUY
$0.46 - $7.2 $2,248 - $35,193
4,888 Added 30.96%
20,674 $10,000
Q2 2022

Aug 15, 2022

SELL
$0.58 - $1.13 $4,387 - $8,547
-7,564 Reduced 32.39%
15,786 $9,000
Q1 2022

May 12, 2022

BUY
$0.73 - $1.81 $915 - $2,269
1,254 Added 5.68%
23,350 $24,000
Q4 2021

Feb 14, 2022

BUY
$1.66 - $2.64 $14,335 - $22,799
8,636 Added 64.16%
22,096 $36,000
Q3 2021

Nov 15, 2021

SELL
$2.58 - $3.36 $27,030 - $35,202
-10,477 Reduced 43.77%
13,460 $36,000
Q2 2021

Aug 16, 2021

SELL
$2.7 - $3.81 $14,755 - $20,821
-5,465 Reduced 18.59%
23,937 $79,000
Q1 2021

May 17, 2021

BUY
$3.02 - $5.16 $65,041 - $111,130
21,537 Added 273.83%
29,402 $97,000
Q4 2020

Feb 16, 2021

SELL
$2.66 - $4.18 $66,555 - $104,587
-25,021 Reduced 76.08%
7,865 $30,000
Q3 2020

Nov 16, 2020

BUY
$3.01 - $3.88 $79,993 - $103,114
26,576 Added 421.17%
32,886 $104,000
Q2 2020

Aug 13, 2020

BUY
$2.33 - $4.6 $6,691 - $13,211
2,872 Added 83.54%
6,310 $20,000
Q1 2020

May 15, 2020

BUY
$1.91 - $4.52 $6,199 - $14,671
3,246 Added 1690.63%
3,438 $9,000
Q4 2019

Feb 07, 2020

SELL
$2.57 - $4.08 $24,435 - $38,792
-9,508 Reduced 98.02%
192 $1,000
Q3 2019

Nov 05, 2019

BUY
$2.74 - $4.65 $26,578 - $45,105
9,700 New
9,700 $32,000
Q2 2019

Aug 13, 2019

SELL
$2.66 - $6.28 $5,500 - $12,987
-2,068 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$2.95 - $5.61 $6,433 - $12,235
-2,181 Reduced 51.33%
2,068 $7,000
Q4 2018

Feb 14, 2019

SELL
$2.3 - $5.78 $6,515 - $16,374
-2,833 Reduced 40.0%
4,249 $13,000
Q3 2018

Nov 13, 2018

BUY
$5.71 - $7.58 $39,067 - $51,862
6,842 Added 2850.83%
7,082 $42,000
Q2 2018

Aug 15, 2018

BUY
$6.68 - $11.0 $1,603 - $2,640
240 New
240 $2,000

Others Institutions Holding MBIO

About MUSTANG BIO, INC.


  • Ticker MBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,222,000
  • Market Cap $27.4M
  • Description
  • Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...
More about MBIO
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.